---
figid: PMC6167501__bsr-38-bsr20180511-g1
figlink: /pmc/articles/PMC6167501/figure/F1/
number: Figure 1
caption: (A) In regular conditions, ligands such as growth factors or mitogens bind
  to the RTK, which is activated by autophosphorylation. Phosphotyrosine residues
  recruit adaptor protein Grb2 and Sos, promoting Ras:GTP association. Activated by
  GAPs such as NF1, Ras hydrolyzes GTP and activates Raf, the first effector kinase
  in the MAPK pathway. Raf then phosphorylates MEK, which in turn phosphorylates ERK.
  p-ERK activates cytoplasmic and nuclear substrates. (B) In melanoma cells, mutations
  in Ras may impair its capacity to hydrolyze GTP, therefore remaining activated.
  Loss of function mutations on NF1 are involved in the same mechanism, promoting
  sustained Ras:GTP association. Mutations in B-Raf kinase are the most frequent in
  melanoma, causing continued phosphorylation of MEK and downstream targets. The pathway
  can be targetted at any level by specific inhibitors.
pmcid: PMC6167501
papertitle: 'Exploring major signaling cascades in melanomagenesis: a rationale route
  for targetted skin cancer therapy.'
reftext: PaolaÂ M. Dantonio, et al. Biosci Rep. 2018 Oct 31;38(5):BSR20180511.
pmc_ranked_result_index: '31841'
pathway_score: 0.982402
filename: bsr-38-bsr20180511-g1.jpg
figtitle: 'Exploring major signaling cascades in melanomagenesis: a rationale route
  for targetted skin cancer therapy'
year: '2018'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6167501__bsr-38-bsr20180511-g1.html
  '@type': Dataset
  description: (A) In regular conditions, ligands such as growth factors or mitogens
    bind to the RTK, which is activated by autophosphorylation. Phosphotyrosine residues
    recruit adaptor protein Grb2 and Sos, promoting Ras:GTP association. Activated
    by GAPs such as NF1, Ras hydrolyzes GTP and activates Raf, the first effector
    kinase in the MAPK pathway. Raf then phosphorylates MEK, which in turn phosphorylates
    ERK. p-ERK activates cytoplasmic and nuclear substrates. (B) In melanoma cells,
    mutations in Ras may impair its capacity to hydrolyze GTP, therefore remaining
    activated. Loss of function mutations on NF1 are involved in the same mechanism,
    promoting sustained Ras:GTP association. Mutations in B-Raf kinase are the most
    frequent in melanoma, causing continued phosphorylation of MEK and downstream
    targets. The pathway can be targetted at any level by specific inhibitors.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CREB3L2
  - CREB5
  - NF1
  - CREB3L3
  - MYC
  - ATF1
  - RPS6KA6
  - MAPK3
  - CREB3L1
  - HRAS
  - RPS6KA3
  - MAP2K2
  - MAPK1
  - SOS2
  - CREB1
  - ATF2
  - CREM
  - CREB3L4
  - RPS6KA2
  - GRB2
  - RPS6KA4
  - RPS6KA5
  - FOS
  - ARAF
  - JUN
  - MUT
  - CREB3
  - SOS1
  - RAF1
  - KRAS
  - RPS6KA1
  - NRAS
  - BRAF
  - MAP2K1
  - Sorafenib
  - Vemurafenib
  - Dobrafenib
  - GDP
  - Selumetinib
  - PDO325901
  - Trametinib
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L2
  entrez: '64764'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB5
  entrez: '9586'
- word: NF1
  symbol: NF1
  source: hgnc_symbol
  hgnc_symbol: NF1
  entrez: '4763'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L3
  entrez: '84699'
- word: Myc
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF1
  entrez: '466'
- word: P90RSK
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA6
  entrez: '27330'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L1
  entrez: '90993'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: P90RSK
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA3
  entrez: '6197'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB1
  entrez: '1385'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF2
  entrez: '1386'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREM
  entrez: '1390'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L4
  entrez: '148327'
- word: P90RSK
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA2
  entrez: '6196'
- word: GrB2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: P90RSK
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA4
  entrez: '8986'
- word: P90RSK
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA5
  entrez: '9252'
- word: Fos
  symbol: FOS
  source: hgnc_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Jun
  symbol: JUN
  source: hgnc_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: MUT
  symbol: MUT
  source: hgnc_symbol
  hgnc_symbol: MUT
  entrez: '4594'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3
  entrez: '10488'
- word: Sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: P90RSK
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA1
  entrez: '6195'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
chemicals:
- word: Sorafenib
  source: MESH
  identifier: C471405
- word: Vemurafenib
  source: MESH
  identifier: C551177
- word: Dobrafenib
  source: ''
  identifier: ''
- word: GDP
  source: MESH
  identifier: D006153
- word: Selumetinib
  source: MESH
  identifier: C517975
- word: PDO325901
  source: MESH
  identifier: C506614
- word: Trametinib
  source: MESH
  identifier: C560077
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
